ask="8.0000"
ask_size="400"
average_daily_volume="46229"
bid="1.0000"
bid_size="100"
book_value="2.7960"
change="-0.0001"
change_from_200_day_moving_average="-1.0918"
change_from_50_day_moving_average="-0.1832"
change_from_52_week_high="-4.6501"
change_From_52_week_low="0.4969"
change_in_percent="-0.0025%"
close="4.0499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.6640"
ebitda="-38.02M"
eps_estimate_current_year="-1.8300"
eps_estimate_next_quarter="-0.5700"
eps_estimate_next_year="-1.9500"
ex_dividend_date="N/A"
float_shares="12976000"
high="4.1000"
high_52_weeks="8.7000"
last_trade_date="2/24/2017"
last_trade_price="4.0499"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.0000"
low_52_weeks="3.5530"
market_capitalization="94.55M"
moving_average_200_day="5.1417"
moving_average_50_day="4.2331"
name="ProQR Therapeutics N.V. - Ordin"
notes="N/A"
one_year_target_price="8.9700"
open="4.0500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-21.2348%"
percent_change_from_50_day_moving_average="-4.3276%"
percent_change_from_52_week_high="-53.4494%"
percent_change_from_52_week_low="+13.9854%"
previous_close="4.0500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.4485"
price_per_sales="33.7564"
revenue="2.80M"
shares_outstanding="23346000"
short_ratio="7.0600"
stock_exchange="NGM"
symbol="PRQR"
volume="27763"
weeks_range_52="3.5530 - 8.7000"
